{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T22:13:09Z","timestamp":1788300789126,"version":"build-2803163510"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001807","name":"FAPESP","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.vaccine.2026.128902","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:17:11Z","timestamp":1783469831000},"page":"128902","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Immunoproteomics and reverse vaccinology identify a protective T-cell epitope from Fonsecaea pedrosoi for experimental chromoblastomycosis"],"prefix":"10.1016","volume":"89","author":[{"given":"Isabela","family":"de Godoy Menezes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz Viana","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata Chaves","family":"Albuquerque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandro Rogerio","family":"de Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2026.128902_bb0005","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1128\/CMR.00032-16","article-title":"Chromoblastomycosis","volume":"30","author":"Queiroz-Telles","year":"2017","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2026.128902_bb0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0009611","article-title":"The global burden of chromoblastomycosis","volume":"15","author":"Santos","year":"2021","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2026.128902_bb0015","first-page":"189","article-title":"Chromoblastomycosis: clinical and mycologic experience of 51 cases","volume":"53","author":"Bonifaz","year":"2010","journal-title":"Mycoses"},{"key":"10.1016\/j.vaccine.2026.128902_bb0020","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nri2939","article-title":"Immunity to fungal infections","volume":"11","author":"Romani","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2026.128902_bb0025","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1146\/annurev-immunol-020711-074958","article-title":"Adaptive immunity to fungi","volume":"30","author":"W\u00fcthrich","year":"2012","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.vaccine.2026.128902_bb0030","first-page":"1698","article-title":"Vaccines for fungal infections","volume":"66","author":"Deepe","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2026.128902_bb0070","first-page":"786","article-title":"Vesicular polysaccharide export in fungal pathogens","volume":"36","author":"Rodrigues","year":"2012","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/j.vaccine.2026.128902_bb0075","first-page":"1129","article-title":"Sequential fractionation and two-dimensional gel analysis unravels the complexity of the Candida albicans cell wall proteome","volume":"3","author":"Pitarch","year":"2004","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.vaccine.2026.128902_bb0080","first-page":"760","article-title":"New advances in the development of a vaccine against paracoccidioidomycosis","volume":"8","author":"Travassos","year":"2017","journal-title":"Front Microbiol"},{"key":"10.1016\/j.vaccine.2026.128902_bb0085","first-page":"557","article-title":"Treatment strategies for cryptococcal infection","volume":"38","author":"Iyer","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128902_bb0110","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1111\/j.1365-2230.2009.03415.x","article-title":"Chromoblastomycosis: clinical presentation and management","volume":"34","author":"Ameen","year":"2009","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.vaccine.2026.128902_bb0115","first-page":"35","article-title":"Fonsecaea-associated chromoblastomycosis","volume":"54","author":"Najafzadeh","year":"2011","journal-title":"Mycoses"},{"key":"10.1016\/j.vaccine.2026.128902_bb0120","first-page":"1","article-title":"Environmental isolation of black fungi involved in chromoblastomycosis","volume":"46","author":"Vicente","year":"2008","journal-title":"Med Mycol"},{"key":"10.1016\/j.vaccine.2026.128902_bb0125","first-page":"291","article-title":"Cell wall composition of Fonsecaea pedrosoi","volume":"30","author":"Alviano","year":"1992","journal-title":"J Med Vet Mycol"},{"key":"10.1016\/j.vaccine.2026.128902_bb0035","first-page":"133","article-title":"Immunological aspects of chromoblastomycosis","volume":"35","author":"Salgado","year":"2010","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.vaccine.2026.128902_bb0040","first-page":"657","article-title":"Fungal vaccines: current status and future prospects","volume":"15","author":"Nanjappa","year":"2014","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.vaccine.2026.128902_bb0045","first-page":"81","article-title":"Recent progress in vaccines against fungal diseases","volume":"25","author":"Cassone","year":"2012","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2026.128902_bb0050","first-page":"14","article-title":"Reverse vaccinology 2.0: human immunology instructs vaccine antigen design","volume":"16","author":"Rappuoli","year":"2018","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.vaccine.2026.128902_bb0055","first-page":"5225","article-title":"Reverse vaccinology: exploiting genomes for vaccine design","volume":"36","author":"Del Tordello","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128902_bb0060","first-page":"678","article-title":"Bioinformatics approaches for epitope-based vaccine design","volume":"18","author":"He","year":"2017","journal-title":"Brief Bioinform"},{"key":"10.1016\/j.vaccine.2026.128902_bb0065","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1128\/IAI.00221-10","article-title":"Paracoccidioides brasiliensis enolase is a surface protein that binds plasminogen","volume":"78","author":"Nogueira","year":"2010","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2026.128902_bb0205","first-page":"1120","article-title":"Fungal vaccines and immunotherapies: emerging strategies against invasive mycoses","volume":"8","author":"Rodrigues","year":"2022","journal-title":"J Fungi (Basel)"},{"key":"10.1016\/j.vaccine.2026.128902_bb0210","article-title":"Antibody-mediated immunity and fungal vaccines","volume":"13","author":"Casadevall","year":"2022","journal-title":"mBio"},{"key":"10.1016\/j.vaccine.2026.128902_bb0215","first-page":"1","article-title":"Medical mycology and fungal immunology: new research directions","volume":"21","author":"Gow","year":"2023","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.vaccine.2026.128902_bb0220","first-page":"1","article-title":"Fungal vaccines: progress and challenges","volume":"23","author":"Brown","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2026.128902_bb0225","article-title":"Vaccines against fungal infections: recent advances and new directions","volume":"77","author":"W\u00fcthrich","year":"2023","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.vaccine.2026.128902_bb0090","article-title":"Vaccine-induced protection against fungal infection","volume":"11","author":"W\u00fcthrich","year":"2015","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2026.128902_bb0095","first-page":"87","article-title":"Role of T-cell subsets in fungal infections","volume":"14","author":"Deepe","year":"2016","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.vaccine.2026.128902_bb0100","first-page":"1","article-title":"Immunoregulation in fungal diseases","volume":"4","author":"Romani","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2026.128902_bb0105","first-page":"1000","article-title":"Chromoblastomycosis: a neglected tropical disease","volume":"15","author":"Queiroz-Telles","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2026.128902_bb0230","first-page":"1","article-title":"The future of antifungal vaccines","volume":"229","author":"Perfect","year":"2024","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2026.128902_bb0235","first-page":"1","article-title":"Vaccines against fungal pathogens","volume":"32","author":"Levitz","year":"2024","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.vaccine.2026.128902_bb0240","first-page":"1","article-title":"Immunological strategies for fungal vaccine development","volume":"45","author":"Deepe","year":"2024","journal-title":"Trends Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26007115?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26007115?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T21:19:58Z","timestamp":1788297598000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26007115"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":33,"alternative-id":["S0264410X26007115"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128902","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunoproteomics and reverse vaccinology identify a protective T-cell epitope from Fonsecaea pedrosoi for experimental chromoblastomycosis","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128902","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"128902"}}